Uncommon Side Effects of Sunitinib Therapy in a Patient with Metastatic Renal Cell Cancer: Case Report

Sunitinib is an orally administered multikinase inhibitor. This therapy can provoke uncommon side effects such as pancytopenia, tumor lysis syndrome, cardiac disorders, thromboembolic incidents, intestinal perforation, pancreatitis, acute renal failure, etc. We report a case of a 63-year-old female...

Full description

Bibliographic Details
Published in:Acta Clinica Croatica
Main Authors: Robert Šeparović, Mirjana Pavlović, Tajana Silovski, Hrvoje Silovski, Ana Tečić Vuger
Format: Article
Language:English
Published: Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2018-01-01
Subjects:
Online Access:https://hrcak.srce.hr/file/315460